BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35981361)

  • 1. [Effect of Netrin-1 on VEGFA Expression in T-ALL Cells and Its Related Mechanism].
    Zhu Y; Liu HY; Xiang Y; Yang H; Yao XY; An XZ; Zhang KN; Huang L; Liang SY; Yu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1049-1055. PubMed ID: 35981361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Netrin-1 in Patients with Acute Lymphoblastic Leukemia and Its Clinical Significance].
    Li YJ; An XZ; Bao BX; Wang HY; Tang X; Yao XY; Liu QH; Zhang LY; Liang SY; Yu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):385-393. PubMed ID: 32319367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Netrin-1 induces the anti-apoptotic and pro-survival effects of B-ALL cells through the Unc5b-MAPK axis.
    Huang L; An X; Zhu Y; Zhang K; Xiao L; Yao X; Zeng X; Liang S; Yu J
    Cell Commun Signal; 2022 Aug; 20(1):122. PubMed ID: 35974411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
    Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
    Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
    Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
    Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous Netrin-1 Inhibits Autophagy of Ischemic Brain Tissues and Hypoxic Neurons via PI3K/mTOR Pathway in Ischemic Stroke.
    Tang T; Gao D; Yang X; Hua X; Li S; Sun H
    J Stroke Cerebrovasc Dis; 2019 May; 28(5):1338-1345. PubMed ID: 30797642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Glucose-Induced Injury to Proximal Tubules of the Renal System Is Alleviated by Netrin-1 Suppression of Akt/mTOR.
    Liu C; Hu X; Zhao Y; Huang A; Chen J; Lu T; Wu M; Lu H
    J Diabetes Res; 2023; 2023():4193309. PubMed ID: 38033740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
    Cani A; Simioni C; Martelli AM; Zauli G; Tabellini G; Ultimo S; McCubrey JA; Capitani S; Neri LM
    Oncotarget; 2015 Mar; 6(9):6597-610. PubMed ID: 25788264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
    Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
    Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus.
    Kazi AA; Molitoris KH; Koos RD
    Biol Reprod; 2009 Aug; 81(2):378-87. PubMed ID: 19420388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential efficacy and prognosis of silencing the CRLF2‑mediated AKT/mTOR pathway in pediatric acute B‑cell lymphoblastic leukemia.
    Jiang M; Zou X; Lu L
    Oncol Rep; 2019 Feb; 41(2):885-894. PubMed ID: 30535452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Netrin-1 restores cell injury and impaired angiogenesis in vascular endothelial cells upon high glucose by PI3K/AKT-eNOS.
    Xing Y; Lai J; Liu X; Zhang N; Ming J; Liu H; Zhang X
    J Mol Endocrinol; 2017 May; 58(4):167-177. PubMed ID: 28250059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.
    Ling Z; Fang ZG; Wu JY; Liu JJ
    Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
    Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular regulation of cervical cancer growth and invasion by VEGFa.
    Chen B; Zhang C; Dong P; Guo Y; Mu N
    Tumour Biol; 2014 Nov; 35(11):11587-93. PubMed ID: 25135429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
    Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
    Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels.
    Bressanin D; Evangelisti C; Ricci F; Tabellini G; Chiarini F; Tazzari PL; Melchionda F; Buontempo F; Pagliaro P; Pession A; McCubrey JA; Martelli AM
    Oncotarget; 2012 Aug; 3(8):811-23. PubMed ID: 22885370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus inhibits insulin release and promotes apoptosis of Min6 cells through the inhibition of the PI3K/Akt/mTOR pathway.
    Tong L; Li W; Zhang Y; Zhou F; Zhao Y; Zhao L; Liu J; Song Z; Yu M; Zhou C; Yu A
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors.
    Batista A; Barata JT; Raderschall E; Sallan SE; Carlesso N; Nadler LM; Cardoso AA
    Exp Hematol; 2011 Apr; 39(4):457-472.e3. PubMed ID: 21277936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.